Catalyst Pharmaceuticals (NASDAQ:CPRX) recently showcased significant growth within its rare disease portfolio, particularly for its lead product, Firdapse. During a discussion with Barclays life sciences analyst...
Barclays has upgraded shares of Analog Devices (NASDAQ: ADI) from an equal weight rating to an overweight rating, reflecting increased confidence in the semiconductor company’s performance....
Sotera Health Company (NASDAQ:SHC) has received a consensus recommendation of “Moderate Buy” from five research firms currently covering the company, according to Marketbeat.com. This assessment reflects...
Cytokinetics, Inc. (NASDAQ: CYTK) has received a price target increase from Citigroup, which raised its target from $77.00 to $84.00, as detailed in a research report...
Financial markets are experiencing significant transformation, driven by advancements in predictive analytics, agentic AI, and hybrid cloud technology. These innovations are reshaping risk management in loan...
